These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

74 related items for PubMed ID: 20074801

  • 1. The proliferative response to CpG-ODN stimulation predicts PFS, TTT and OS in patients with chronic lymphocytic leukemia.
    Tarnani M, Laurenti L, Longo PG, Piccirillo N, Gobessi S, Mannocci A, Marietti S, Sica S, Leone G, Efremov DG.
    Leuk Res; 2010 Sep; 34(9):1189-94. PubMed ID: 20074801
    [Abstract] [Full Text] [Related]

  • 2. The Akt signaling pathway determines the different proliferative capacity of chronic lymphocytic leukemia B-cells from patients with progressive and stable disease.
    Longo PG, Laurenti L, Gobessi S, Petlickovski A, Pelosi M, Chiusolo P, Sica S, Leone G, Efremov DG.
    Leukemia; 2007 Jan; 21(1):110-20. PubMed ID: 17024114
    [Abstract] [Full Text] [Related]

  • 3. [Chromosome study on chronic lymphocytic leukemia using CpG-oligodeoxynucleotide as immunostimulant agent].
    Wu Y, Xue Y, Chen S, Yao L, Jiang H, Zhang J, Shen J, Pan J, Wang Y, Bai S.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Feb; 27(1):86-91. PubMed ID: 20140876
    [Abstract] [Full Text] [Related]

  • 4. Down-regulation of CXCR4 and CD62L in chronic lymphocytic leukemia cells is triggered by B-cell receptor ligation and associated with progressive disease.
    Vlad A, Deglesne PA, Letestu R, Saint-Georges S, Chevallier N, Baran-Marszak F, Varin-Blank N, Ajchenbaum-Cymbalista F, Ledoux D.
    Cancer Res; 2009 Aug 15; 69(16):6387-95. PubMed ID: 19654311
    [Abstract] [Full Text] [Related]

  • 5. Prognostic relevance of the FAB morphological criteria in chronic lymphocytic leukemia: correlations with IgVH gene mutational status and other prognostic markers.
    Schwarz J, Mikulenková D, Cermáková M, Polanská V, Michalová K, Marinov I, Campr V, Ransdorfová S, Marková J, Pavlistová L, Brezinová J, Sajdová J, Sponerová D, Volková Z, Benesová K, Cermák J, Vítek A, Cetkovský P.
    Neoplasma; 2006 Aug 15; 53(3):219-25. PubMed ID: 16652191
    [Abstract] [Full Text] [Related]

  • 6. Immunostimulatory oligodeoxynucleotides induce apoptosis of B cell chronic lymphocytic leukemia cells.
    Jahrsdörfer B, Wooldridge JE, Blackwell SE, Taylor CM, Griffith TS, Link BK, Weiner GJ.
    J Leukoc Biol; 2005 Mar 15; 77(3):378-87. PubMed ID: 15582984
    [Abstract] [Full Text] [Related]

  • 7. Modulation of malignant B cell activation and apoptosis by bcl-2 antisense ODN and immunostimulatory CpG ODN.
    Jahrsdörfer B, Jox R, Mühlenhoff L, Tschoep K, Krug A, Rothenfusser S, Meinhardt G, Emmerich B, Endres S, Hartmann G.
    J Leukoc Biol; 2002 Jul 15; 72(1):83-92. PubMed ID: 12101266
    [Abstract] [Full Text] [Related]

  • 8. Combined treatment of CpG-oligodeoxynucleotide with Nutlin-3 induces strong immune stimulation coupled to cytotoxicity in B-chronic lymphocytic leukemic (B-CLL) cells.
    Secchiero P, Melloni E, Tiribelli M, Gonelli A, Zauli G.
    J Leukoc Biol; 2008 Feb 15; 83(2):434-7. PubMed ID: 17998303
    [Abstract] [Full Text] [Related]

  • 9. Differential regulation of B-cell proliferation by IL21 in different subsets of chronic lymphocytic leukemia.
    Ghalamfarsa G, Jadidi-Niaragh F, Hojjat-Farsangi M, Asgarian-Omran H, Yousefi M, Tahmasebi F, Khoshnoodi J, Razavi SM, Saboor-Yaraghi AA, Rabbani H, Jeddi-Tehrani M, Shokri F.
    Cytokine; 2013 Jun 15; 62(3):439-45. PubMed ID: 23579027
    [Abstract] [Full Text] [Related]

  • 10. Impact of trisomy 12, del(13q), del(17p), and del(11q) on the immunophenotype, DNA ploidy status, and proliferative rate of leukemic B-cells in chronic lymphocytic leukemia.
    Quijano S, López A, Rasillo A, Sayagués JM, Barrena S, Sánchez ML, Teodosio C, Giraldo P, Giralt M, Pérez MC, Romero M, Perdiguer L, Orfao A.
    Cytometry B Clin Cytom; 2008 May 15; 74(3):139-49. PubMed ID: 18061951
    [Abstract] [Full Text] [Related]

  • 11. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
    Kardum-Skelin I, Planinc-Peraica A, Ostojić Kolonić S, Radić-Kristo D, Milas M, Vrhovac R, Sustercić D, Minigo H, Jaksić B.
    Acta Med Croatica; 2008 Oct 15; 62(4):351-64. PubMed ID: 19205412
    [Abstract] [Full Text] [Related]

  • 12. Circulating endothelial cells in patients with chronic lymphocytic leukemia: clinical-prognostic and biologic significance.
    Rigolin GM, Maffei R, Rizzotto L, Ciccone M, Sofritti O, Daghia G, Cibien F, Cavazzini F, Marasca R, Cuneo A.
    Cancer; 2010 Apr 15; 116(8):1926-37. PubMed ID: 20166207
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of trisomy 12 by fluorescence in situ hybridization in peripheral blood, bone marrow and lymph nodes of patients with B-cell chronic lymphocytic leukemia.
    Liso V, Capalbo S, Lapietra A, Pavone V, Guarini A, Specchia G.
    Haematologica; 1999 Mar 15; 84(3):212-7. PubMed ID: 10189384
    [Abstract] [Full Text] [Related]

  • 14. Serum insulin-like growth factor is not elevated in patients with early B-cell chronic lymphocytic leukemia but is still a prognostic factor for disease progression.
    Molica S, Vitelli G, Mirabelli R, Digiesu G, Giannarelli D, Cuneo A, Ribatti D, Vacca A.
    Eur J Haematol; 2006 Jan 15; 76(1):51-7. PubMed ID: 16343271
    [Abstract] [Full Text] [Related]

  • 15. Select high-risk genetic features predict earlier progression following chemoimmunotherapy with fludarabine and rituximab in chronic lymphocytic leukemia: justification for risk-adapted therapy.
    Byrd JC, Gribben JG, Peterson BL, Grever MR, Lozanski G, Lucas DM, Lampson B, Larson RA, Caligiuri MA, Heerema NA.
    J Clin Oncol; 2006 Jan 20; 24(3):437-43. PubMed ID: 16344317
    [Abstract] [Full Text] [Related]

  • 16. IgVH mutational status and clonality analysis of Richter's transformation: diffuse large B-cell lymphoma and Hodgkin lymphoma in association with B-cell chronic lymphocytic leukemia (B-CLL) represent 2 different pathways of disease evolution.
    Mao Z, Quintanilla-Martinez L, Raffeld M, Richter M, Krugmann J, Burek C, Hartmann E, Rudiger T, Jaffe ES, Müller-Hermelink HK, Ott G, Fend F, Rosenwald A.
    Am J Surg Pathol; 2007 Oct 20; 31(10):1605-14. PubMed ID: 17895764
    [Abstract] [Full Text] [Related]

  • 17. All-trans-retinoic Acid differentially regulates proliferation of normal and leukemic B cells from different subsets of chronic lymphocytic leukemia.
    Ghalamfarsa G, Jadidi-Niaragh F, Amiri MM, Razavi SM, Saboor-Yaraghi AA, Shokri F.
    Nutr Cancer; 2015 Oct 20; 67(2):285-91. PubMed ID: 25611428
    [Abstract] [Full Text] [Related]

  • 18. Clinical tumor cell distribution pattern is a prognostically relevant parameter in patients with B-cell chronic lymphocytic leukemia.
    Jaksic O, Vrhovac R, Kusec R, Kardum MM, Pandzic-Jaksic V, Kardum-Skelin I, Planinc-Peraica A, Morabito F, Brugiatelli M, Jaksic B.
    Haematologica; 2001 Aug 20; 86(8):827-36. PubMed ID: 11522539
    [Abstract] [Full Text] [Related]

  • 19. Prognostic significance of lymphocyte morphology in patients with advanced chronic lymphocytic leukemia treated with first line therapy of fludarabine + prednisone.
    Mauro FR, Gentile M, Mancini F, Giannarelli D, Guarini A, De Propriis MS, Cerretti R, Foa R.
    Haematologica; 2002 Jun 20; 87(6):602-8. PubMed ID: 12031916
    [Abstract] [Full Text] [Related]

  • 20. B-cell lymphomas differ in their responsiveness to CpG oligodeoxynucleotides.
    Jahrsdorfer B, Mühlenhoff L, Blackwell SE, Wagner M, Poeck H, Hartmann E, Jox R, Giese T, Emmerich B, Endres S, Weiner GJ, Hartmann G.
    Clin Cancer Res; 2005 Feb 15; 11(4):1490-9. PubMed ID: 15746051
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.